Florida · 2025 Regular Session · Bill
SB 1676: Diabetes Management
Did not advance Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
- Did not advance
Last official action: ·Record last updated:
Plain-language summary
SB 1676 is a bill introduced in the Florida Senate on February 28, 2025. According to its official title, it concerns: Diabetes Management. Primary sponsor: Smith. It lists 1 additional sponsor. Most recent recorded action (June 16, 2025): Died in Health Policy.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Diabetes Management; Requiring the Department of Health to create and maintain a website; authorizing a pharmacist to prescribe and dispense a 30-day supply of insulin drugs, glucagon drugs, diabetes devices, and diabetic ketoacidosis devices under certain circumstances; requiring health insurance policies and health maintenance contracts, respectively, to provide coverage for laboratory and diagnostic testing and screening for diabetes under certain circumstances; requiring a dispenser to report to the electronic health recordkeeping system certain drugs and devices dispensed, etc.
Sponsors
Sponsors by party (alphabetical): Democratic 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Smith | Primary sponsor | Not applicable (committee) | — | — |
| Tracie Davis | Co-sponsor | Democratic | Senate | 5 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Died in Health Policy
- Indefinitely postponed and withdrawn from consideration
- Introduced
- Referred to Health Policy; Appropriations Committee on Health and Human Services; Fiscal Policy
- Filed